Cardiovascular and non-cardiovascular mortality in dialysis patients: Where is the link?

Kidney International Supplements

Volumn 1, Issue 1, 2011, Pages 21-23

  Jager, Kitty J ^a   Lindholm, Bengt ^b   Goldsmith, David ^c   Fliser, Danilo ^d   Wiecek, Andrzej ^e   Suleymanlar, Gultekin ^f   Ortiz, Alberto ^g   Massy, Ziad ^h,i   Martinez Castelao, Alberto ^j   Agarwal, Rajiv ^k   Blankestijn, Peter J ^l   Covic, Adrian ^m   London, Gerard ⁿ   Zoccali, Carmine ^o   Dekker, Friedo W ^p  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d SAARLAND UNIVERSITY   (Germany)

^e MEDICAL UNIVERSITY OF SILESIA   (Poland)

^f AKDENIZ UNIVERSITY   (Turkey)

^g UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^h INSERM   (France)

ⁱ AMIENS UNIVERSITY HOSPITAL   (France)

^j HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^k INDIANA UNIVERSITY   (United States)

^l UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^m C I PARHON NATIONAL INSTITUTE OF ENDOCRINOLOGY   (Romania)

ⁿ PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^o CNR   (Italy)

^p LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

cardiovascular disease; cardiovascular mortality; dialysis; mortality; non cardiovascular mortality; renal replacement therapy

Indexed keywords

EID: 84879621359     PISSN: 21571724     EISSN: 21571716     Source Type: Journal    
DOI: 10.1038/kisup.2011.7     Document Type: Review

References (17)

1. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32(Suppl 3): S112-S119. (Pubitemid 28527268)
2. de Jager DJ, Grootendorst DC, Jager KJ et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 2009; 302: 1782-1789.
3. Sarnak MJ, Jaber BL Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 2000; 58: 1758-1764.
4. Sarnak MJ, Jaber BL. Pulmonary infectious mortality among patients with end-stage renal disease. Chest 2001; 120: 1883-1887. (Pubitemid 34053449)
5. Fried LF, Katz R, Sarnak MJ et al. Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol 2005; 16: 3728-3735. (Pubitemid 46211295)
6. Drueke TB, Massy ZA. Atherosclerosis in CKD: differences from the general population. Nat Rev Nephrol 2010; 6: 723-735.
7. Wanner C, Krane V, Marz W et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353: 238-248. (Pubitemid 41058323)
8. Fellstrom BC, Jardine AG, Schmieder RE et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009; 360: 1395-1407.
9. Drueke TB, Locatelli F, Clyne N et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006; 355: 2071-2084. (Pubitemid 44749316)
10. Singh AK, Szczech L, Tang KL et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 355: 2085-2098. (Pubitemid 44749317)
11. Stengel B. Chronic kidney disease and cancer: a troubling connection. J Nephrol 2010; 23: 253-262.
12. Kaysen GA. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 2001; 12: 1549-1557. (Pubitemid 32666340)
13. Kato S, Chmielewski M, Honda H et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 2008; 3: 1526-1533.
14. Stenvinkel P, Ketteler M, Johnson RJ et al. IL-10, IL-6, and TNF-a: central factors in the altered cytokine network of uremia-the good, the bad, and the ugly. Kidney Int 2005; 67: 1216-1233. (Pubitemid 40463099)
15. Smeeth L, Thomas SL, Hall AJ et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004; 351: 2611-2618. (Pubitemid 39628582)
16. Ishani A, Collins AJ, Herzog CA et al. Septicemia, access and cardiovascular disease in dialysis patients: the USRDS wave 2 study. Kidney Int 2005; 68: 311-318. (Pubitemid 43181390)
17. Jager KJ, Stel VS, Zoccali C et al. The issue of studying the effect of interventions in renal replacement therapy-to what extent may we be deceived by selection and competing risk? Nephrol Dial Transplant 2010; 25: 3836-3839.